首页> 外文期刊>Pathology International >Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.
【24h】

Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas.

机译:胰腺导管内乳头状黏液性肿瘤中claudin-1和claudin-4的不同表达模式。

获取原文
获取原文并翻译 | 示例
           

摘要

The expression of claudin-4 was investigated in human pancreas, pancreatic ductal adenocarcinomas, and intraductal papillary-mucinous tumors of the pancreas (IPMT), and compared with that of claudin-1. In human adult pancreatic specimens, both claudin-1 and claudin-4 were immunohistochemically found in main and branching pancreatic ducts, terminal ductules and acinic cells, with the exception of endocrine cells. Of 12 cases of pancreatic ductal adenocarcinoma, 11 (92%) had positive immunostaining for claudin-4, and seven (58%) for claudin-1. In 44 lesions of 22 cases of IPMT, including six hyperplastic foci distant from the main lesions, clauidin-1 was positive in three out of six (50%) hyperplastic foci, 14 out of 17 (82%) adenomas, three out of 10 (30%) borderline tumors, two out of six (33%) non-invasive carcinomas, and one out of five (20%) invasive carcinomas, producing a statistically negative correlation with histological tumor grades. In contrast, claudin-4 was negative in the six hyperplastic foci, and positive in four out of the 17 (24%) adenomas, five out of the 10 (50%) borderline tumors, five out of the six (83%) non-invasive carcinomas, and four out of the five (80%) invasive carcinomas, producing a statistically positive correlation with histological tumor grades. On study of IPMT subtypes, claudin-1 was positive in nine out of 10 (90%) clear-cell types, seven out of 20 (35%) dark-cell types, and four out of eight (50%) compact-cell types. In contrast, claudin-4 was positive in two out of the 10 (20%) clear-cell types, 13 out of the 20 (65%) dark-cell types, and three out of the eight (38%) compact-cell types. These distinct expression patterns of claudin-1 and claudin-4 suggest that both claudins serve as useful molecular markers for the tumor classification of IPMT.
机译:研究了claudin-4在人胰腺,胰腺导管腺癌和胰管内乳头状黏液性肿瘤(IPMT)中的表达,并与claudin-1进行了比较。在成人胰腺标本中,除了内分泌细胞外,在主要和分支胰管,终末小管和腺泡细胞中都免疫组化发现了claudin-1和claudin-4。在12例胰腺导管腺癌中,有11例(92%)的claudin-4免疫染色阳性,而7例(58%)的claudin-1免疫染色阳性。在22例IPMT患者的44个病变中,包括远离主要病变的6个增生灶,clauidin-1在6个增生灶中占3个(50%)为阳性,在17个腺瘤中占14个(82%)为阳性,在10个腺瘤中有3个(30%)交界性肿瘤,六分之二(33%)的非浸润性癌和五分之一(20%)的浸润性癌,与组织学肿瘤分级在统计学上呈负相关。相比之下,claudin-4在六个增生灶中为阴性,在17个(24%)腺瘤中有四个为阳性,在10个(50%)边缘性肿瘤中为五个,在六个非增生性肿瘤中为五个(83%) -浸润性癌,五分之四(80%)浸润性癌与组织学肿瘤分级在统计学上呈正相关。在IPMT亚型研究中,claudin-1在10个透明细胞类型中占9个(90%),20个(35%)暗细胞类型中有7个,在8个紧凑型细胞(50%)中具有4个阳性类型。相比之下,claudin-4在10种(20%)透明细胞类型中有两种是阳性的,在20种(65%)暗细胞类型中有13种,在8种(38%)紧凑型细胞中有3种是阳性的类型。 claudin-1和claudin-4的这些不同表达模式表明,两种claudin均可用作IPMT肿瘤分类的有用分子标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号